When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Treatment and management of COVID-19 - Wikipedia

   en.wikipedia.org/wiki/Treatment_and_management...

   This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic. [85] [86] [87]

3. Systems medicine - Wikipedia

   en.wikipedia.org/wiki/Systems_medicine

   This branch of systems medicine, going back to the traditions of Ludwig von Bertalanffy's systems theory and biological cybernetics is a top-down strategy that starts with the description of large, complex processing structures (i.e. neural networks, feedback loops and other motifs) and tries to find sufficient and necessary conditions for the corresponding functional organisation on a ...

4. COVID-19 drug development - Wikipedia

   en.wikipedia.org/wiki/COVID-19_drug_development

   Bebtelovimab is a neutralizing human immunoglobulin G1 (IgG1) monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19.

5. Chloroquine and hydroxychloroquine during the COVID-19 ...

   en.wikipedia.org/wiki/Chloroquine_and_hydroxych...

   The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]

6. NRICM101 - Wikipedia

   en.wikipedia.org/wiki/NRICM101

   11 formulations based on the NRICM101 prescription. NRICM101 (Chinese: 清冠一號; Taiwan: Chingguan Yihau; Mainland: Qīng-guān Yī-hào), is a treatment for COVID-19 developed in Taiwan using Traditional Chinese Medicine (TCM), created by the National Research Institute of Chinese Medicine (NRICM), a governmental body of Taiwan. [1]

7. Older adults at higher risk of long COVID; shots don't prevent it

   www.aol.com/news/older-adults-higher-risk-long...

   Research in U.S. veterans provides fresh evidence that long COVID-19 can happen even after breakthrough infections following vaccination.